📈 $LLYB : Eli Lilly — the rally continues, but will there be a correction?
Tokenized Eli Lilly shares ($LLYB ) are showing strong upward momentum. Over the past 7 days, the price has risen by approximately 11%, reaching $1,430.
💊 Fundamental support comes from demand for Mounjaro and Zepbound, strong financial results, and the prospects for the obesity-treatment market.
🔎 What’s next?
🟢 Bullish scenario: a breakout above resistance at $1,450–1,455 could open the way to $1,470–1,500.
🟡 Base scenario: consolidation in the $1,400–1,455 range after the rapid rise.
🔴 Bearish scenario: a loss of support at $1,400 could trigger a pullback to $1,325–1,350.
These are technical levels, not a guaranteed forecast. After such a rally, the risk of a short-term correction increases.
💡 My strategy: I’m considering taking partial profits while keeping my core position for possible further gains.
What would you choose: taking profits or holding $LLYB for the long term?
#LLYB #EliLilly #BStocks #Investing #stockmarket
Tokenized Eli Lilly shares ($LLYB ) are showing strong upward momentum. Over the past 7 days, the price has risen by approximately 11%, reaching $1,430.
💊 Fundamental support comes from demand for Mounjaro and Zepbound, strong financial results, and the prospects for the obesity-treatment market.
🔎 What’s next?
🟢 Bullish scenario: a breakout above resistance at $1,450–1,455 could open the way to $1,470–1,500.
🟡 Base scenario: consolidation in the $1,400–1,455 range after the rapid rise.
🔴 Bearish scenario: a loss of support at $1,400 could trigger a pullback to $1,325–1,350.
These are technical levels, not a guaranteed forecast. After such a rally, the risk of a short-term correction increases.
💡 My strategy: I’m considering taking partial profits while keeping my core position for possible further gains.
What would you choose: taking profits or holding $LLYB for the long term?
#LLYB #EliLilly #BStocks #Investing #stockmarket